Thursday, March 2, 2017. Click here to register. Continuing education for this activity is available.
Describe three objectives of the Antiretroviral Pregnancy Registry (APR).
List two key findings from analysis of APR data.
Describe four steps to report a drug exposure to the APR.
CDC MMWR Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs — United States
Persons who inject drugs (PWID) are at higher risk for human immunodeficiency virus (HIV) infection, and the U.S. National HIV/AIDS Strategy identifies PWID as a priority population for HIV prevention. Although AIDS diagnoses among PWID have decreased almost 90% since their peak in 1993 and only an estimated 0.3% of the U.S. population has injected drugs in the past 12 months, approximately 9% of HIV infections diagnosed in recent years are among PWID. HIV diagnoses among PWID have decreased over time; however, recent increases in acute hepatitis C virus infections, which are frequently associated with injection drug use, suggest this progress could be negatively affected by increases in opioid and heroin use. Although, decreases in HIV diagnoses among PWID indicate success in HIV prevention, emerging behavioral and demographic trends could reverse this success.